Dxgen exhibited AACC Clinical Lab Expo, 1-3 August in San Diego, CA, USA. The expo provides opportunity to connect with global leaders in clinical chemistry, molecular diagnostics, mass spectrometry, translational medicine, lab management, and other areas of breaking science in laboratory medicine.
Epithod®616 as world 1st Point-of-Care system for Glycated Albumin and HbA1c was introduced in US and Latin America market. Especially, Glycated Albumin as a new marker in POCT received great attention at AACC Clinical Lab Expo. We had productive meeting with potential buyers all over the world and had a chance to establish successful business partnership with esteemed company. We sincerely appreciate your continuous support and interest in our product.